| Title | Cell and molecular biology of breast cancer | |
| Authors | Joyce Taylor-Papadimitriou, Joy M. Burchell, Caroline Whitehouse, Michael Smith, Rosalind Graham, Moira Shearer and Deborah Alford
Imperial Cancer Research Fund, 44 Lincolns Inn Fields London WC2A 3PX UK |
|
| Citation | Taylor-Papadimitriou, J., Burchell, J.M. Whitehouse, C., Smith, M., Graham, R. et al.: Cell and molecular biology of breast cancer, Epitheorese Klin. Farmakol. Farmakokinet. 11(1): 40-46 (1997) | |
| Publication Date | Accepted for publication: 15 April 1997 | |
| Full Text Language | English | |
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
|
| Keywords | Breast cancer, cell and molecular biology. | |
| Other Terms | review article | |
| Summary | The MUC1 gene was the first mucin gene to be cloned and is unique among the epithelial mucins in being a transmembrane molecule. Since it is over-expressed and aberrantly giycosylated in breast and other carcinomas, it is being used widely as a model for studies on mucin type O-glycosylation and as a candidate cancer vaccine. Our studies on the giycosylation of MUC1 have shown a correlation between changes in the profile of glycosyl transferases and the changes in O-glycan structure seen in Breast Cancer. The generality of the changes and the control of expression of the relevant glycosyl transferases is being pursued. Our results also suggest that there are fewer O-glycans added to the cancer mucin than to the normal mucin and the expression of the various GalNAc transferases is under investigation. Pre-clinical studies are being combined with Clinical studies to attempt to use MUC1 based immunogens in the management of Breast Cancer. Our own effects are focused on developing a DNA based vaccine and on evaluating 1) the effect of giycosylation on immunogenicity of the mucin and 2) the importance of HLA restricted presentation. In analyzing the molecular mechanisms involved in the loss of tissue architecture seen in breast carcinomas, the detailed characterisation of cell phenotype has we believe, played a crucial role in identifying the a2β1 integrin as a major player in the maintenance of tissue integrity and as a target for c-erbB2 signalling through the ras pathway. | |
| References | 1. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122 (1994)
2. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF: Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10: 1673-1675 (1995) 3. Bartek J, Taylor-Papadimitriou J, Miller N, Millis R: Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int. J. Cancer 36: 299-306 (1985) 4. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94: 403-413 (1989) 5. Taylor-Papadimitriou J, Wetzels R, Ramaekers F: Inter-mediate filament protein expression in normal and malignant human mammary epithelial cells. In: Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer (RB Dickson, ME Lippman, eds), pp. 355- 378, Kluwer Academic Publishers, Boston, 1991 6. Bartek J, Bartkova J, Lalani E-N, Brezina V, Taylor-Papadimitriou J: (1990) Selective immortalisation of a phenotypically distinct epithelial cell type by microinjection of SV40 DNA into cultured human milk cells. Int. J. Cancer 45: 1105- 1112 (1990) 7. Bartek J, Bartkova J, Kyprianou N, Lalani E-N, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J: Efficient immortalisation of luminal epithelial cells from the human mammary gland by introduction of SV40 large T antigen using a recombinant retrovirus. Proc. Natl. Acad. Sci. USA. 88: 3520-3524 (1991) 8. Taylor-Papadimitriou J, Berdichevsky F, D’Souza B, Burchell J: (1993) Human Models of Breast Cancer. Cancer Surveys: Mot. Pathol. Cancer 16: 59-78 (1993) 9. Berdichevsky F, Wetzels R, Shearer M, Martignone S, Raemakers FCS, Taylor-Papadimitriou J: Integrin expression in relation to cell phenotype and malignant change in the human breast. Mol. Cell Diff. 2: 255-274 (1994) 10. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J: bcl2 Overexpression Inhibits Apoptosis and promotes the Phenotypic and Morphological Differentiation of Human Mammary Epithelial Cells. J. Ceil Biol. 129: 1363-1378 (1995) 11. Berdichevsky F, Alford D, D’Souza B, Taylor-Papadimitriou J: (1994) Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107: 3557- 3568 (1994) 12. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani E-N, Wilson D: Molecular cloning and expression of the human tumour-associated polymorphic epithelial mucin. J. Biol. Chem. 265: 15286-15293 (1990) 13. Pemberton L, Ruhgetti A, Taylor-Papadimitriou J, Gendler SG: The Epithelial Mucin MUC1 Contains at Least Two Discrete Signals Specifying Membrane Localization in Cells. J. Biol. Chem. 271: 2332-2340 (1996) 14. Taylor-Papadimitriou J, Peat N, Graham R, Burchell J: Aberrant glycosylation of the MUC1 gene product in adenocarcinomas: Implications for immunotherapy. Complex Carbohydrates in Drug Research (Eds K Bock, H Clausen, Munksgaard, Copenhagen). Alfred Benzon Symposium 36: 382-393 (1994) 15. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF: Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int. J. Cancer 28: 17-21 (1981) 16. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D: Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47: 5476-5482 (1987) 17. Jerom KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast PC, Jr, Finn OJ: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51: 29-08-2916 (1991) 18. von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, Litvinov SV, van Kamp GJ, Meijer S, Vermorken J, Hilgers J: Humoral immune responses to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur. J. Can. 32A: 325-1331 (1996) 19. Jerome KR, Domenech N, Finn OJ: (1993) Tumor-specific cytotoxic T-cell clones from patients with breast and pancreatic adenocarcinoma regocnise EBV-immortalized B- cells transfected with polymortphic epithelial mucin complementary-DNA. J. Immun. 151: 1654-1662 (1993) 20. Finn OJ: (1993) Tumor-rejection antigens recognised by T-lymphocytes. Curr. Opin. Immun. 5: 701-708 (1993) 21. White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H: Purification and cDNA cloning of a human UDP- N-acetyl-a-D-galacotsamine :polypeptide N-acetylgalactosaminyltransferase J. Biol. Chem. 270: 24156-24165 (1995) 22. Sorensen T, White T, Wandall HH, Krrstensen AK, Roepstorff P, Clausen H: UDP-N-acetyl-a-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase: Identification and separation of two distinct transferase activities. J. Biol. Chem. 270: 24166-24173 (1995) 23. Hanisch F-G, Uhlenbruck G, katalinic JP, Egge H, Dabrowski J, Dabrowski U: Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. J. Biol. Chem. 264: 872-883 (1989) 24. Hanisch F-G, Katalinic JP, Egge H, Dabrowski U, Uhlenbruck G: Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins. Glycoconjugate J. 7: 525- 543 (1990) 25. Brockhausen I: Biosynthesis of O-glycans of the N-acetylgalactosamine-a-Ser/Thr linkage type. In: Glycoproteins (Montreuil J, Schächter H, Vliegentharts JFG eds) Elseveir Pub., 1996. 26. Girling A, Bartkova J, Burchell J, Gender S, Gillett C, Taylor-Papadimitriou J: (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J, Cancer 43: 1072-1076 (1989) 27. Burchell J, Taylor-Papadimitriou J: Effect of modification of carbohydrate side chain on the reactivity of antibodies with core protein epitopes of the MUC1 gene product. Epithelial Cell Biol, 2: 155-162 (1983) 28. Lloyd KO, Burchell JM, Kudryashov V, Yin BWT, Taylor-Papadimitriou J: Comparison of O-linked carbohydrate chains in MUC1 mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma cell lines – Demonstration of a simplified glycosylation pattern in tumor cells. J. Biol. Chem. (1996) 29. Brockhausen I, Yang JM, Burchell JM, Whitehouse, Taylor-Papadimitriou J: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Bur. J. Biochem. 233: 607-617 (1995) 30. Böhm C.M, Mulder MC, Zennadi R, Notter M, Schmitt- Graff A, Finn OJ, Taylor-Papadimitriou J, Stein H, Clausen H, Riecken EO, Hanski C: (1996) Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation. Int. J. Immunol. (1996) 31. Domenech N, Henderson RA, Finn OJ: Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumour antigen mucin. J. Immun. 25: 4766-4774 (1995) 32. Lalani E-N, Berdichevsky F, Boshell M, Shearer M, Wilson D, Stauss H, Gendler SJ, Taylor-Papadimitriou J: (1991) Expression of the gene coding for a human mucin in mouse mammary tumour cells can affect their tumorigenicity. J. Biol. Chem. 266: 15420-15426 (1991) 33. Graham RA, Stewart LS, Peat NP, Beverley P, Taylor-Papadimitriou J: (1996) MUC1 based immunogens for tumour targeting: Development of murine model systems. Tumour Targeting 1: 211-221 (1996) 34. Peat N, Gendler SJ, Lalani E-N, Duhig T, Taylor-Papadimitriou J: (1992) Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res. 52: 1954-1960 (1992) 35. Alford D, Taylor-Papadimitriou J: Cell Adhesion Molecules in the Normal and Cancerous Breast. J. Mammary Gland Biol. Neoplasia 1: 207-218 (1996) 36. Takeichi M: Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7: 619-627 (1995) 37. Moli R, Mitze M, Frixen UH, Birchmeier W: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 143: 1731-1742 (1993) 38. Schwartz MA, Shaller MD, Ginsberg MH: INTEGRINS: Emerging paradigms of signal transduction. Annu. Rev. Cell Div. Biol. 11: 549-99 (1995) 39. Stepp MA, Spurr-Michaud S, Tisdale A, Elwell J, Gipson IK: a6b4 integrin heterodimer is a component of hemidesmosomes. Proc, Natl. Acad. Sci. USA. 87: 8970- 8974 (1990) 40. Sonnemberg A, Calafat J, Janssen H, Daams H, van der Raaji-Jelmer LMH, Falcioni R, Kennel SJ, Aplin JD, Baker J, Loizidou M, Garrod D: Intergrin a6b4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J. Cell Biol. 113: 907-917 (1991) 41. Pignatelli M, Hanby AM, Stamp GW: Low expression of beta 1, alpha 2, and alpha 3 subunits of VLA integrins in malignant mammary tumors. J. Pathol. 165: 25-32 (1991) 42. Shearer M, Bartkova J, Bartek J, Berdichevsky F, Barnes D, Millis R, Taylor-Papadimitriou J: Studies on clonal cell lines development from primary breast cancers indicate that the ability to undergo morphogenesis in vitro is lost early in malignancy. Int. J. Cancer 51: 602-612 (1992) 43. Lu QL, Poulsom R, Wong L, Hanby AM: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 169: 431-437 (1993) 44. D’Souza B, Taylor-Papadimitriou J: Overexpression of c-erbB-2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc. Natl. Acad. Sci. 91: 7202-7206 (1994) 45. Lu PJ, Lu Ql, Rughetti A, Taylor-Papadimitriou J: bcl2 Overexpression Inhibits Apoptosis and promotes the Pheno-typic and MOrphological Differenctiation of Human Mammary Epithelial Cells. J. Cell. Biol. 129: 1363-1378 (1995) 46. Ye J, Xu RH, Taylor-Papadimitriou J. Pitha PM: The Sp-1 Binding Plays a Critical Role in Erb-B2 and v-Ras-mediated Downregulation of a2 Integrin Expression in Human Mammary Epithelial Cells. Mol. Cell. Biol. (1996) 47. Yang Y, Spitzer E, Meyer D, Sachs M, Neimann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W: Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell. Biol. 131: 215-226 (1995) |
|
| Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1997 – ANNUAL SUBSCRIPTION 1997 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|